Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.86 USD | -22.69% | -29.23% | +31.39% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Financials (USD)
Sales 2024 * | 68.34M | Sales 2025 * | 84.72M | Capitalization | 871M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -108M | EV / Sales 2024 * | 12.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.3 x |
P/E ratio 2024 * |
-6.72
x | P/E ratio 2025 * |
-6.81
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.32% |
Latest transcript on Ocular Therapeutix, Inc.
1 day | -22.69% | ||
1 week | -29.23% | ||
Current month | -35.60% | ||
1 month | -37.92% | ||
3 months | +49.11% | ||
6 months | +146.74% | ||
Current year | +31.39% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 17-09-24 |
Chief Tech/Sci/R&D Officer | - | 21-09-27 | |
Rabia Ozden
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 23-07-09 |
Director/Board Member | 76 | 12-11-04 | |
Merilee Raines
BRD | Director/Board Member | 68 | 21-09-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +4.47% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 5.86 | -22.69% | 6,074,050 |
24-04-17 | 7.58 | -2.70% | 983,500 |
24-04-16 | 7.79 | -0.13% | 1,343,559 |
24-04-15 | 7.8 | -2.38% | 1,496,201 |
24-04-12 | 7.99 | -3.50% | 1,037,521 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.39% | 871M | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- OCUL Stock